[1]
|
Fitzmaurice, C., Allen, C., Barber, R.M., Barregard, L., Bhutta, Z.A., Brenner, H., et al. (2017) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology, 3, 524-548. https://doi.org/10.1001/jamaoncol.2016.5688
|
[2]
|
Huang, T.-L., Chien, C.-Y., Tsai, W.-L., Liao, K.-C., Chou, S.-Y., Lin, H.-C., et al. (2016) Long-Term Late Toxicities and Quality of Life for Survivors of Naso-pharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy versus Non-Intensity-Modulated Radiotherapy. Head & Neck, 38, E1026-E1032. https://doi.org/10.1002/hed.24150
|
[3]
|
Song, T., Fang, M., Zhang, X.-B., Zhang, P., Xie, R.-F. and Wu, S.-X. (2015) Sustained Improvement of Quality Of life for Nasopharyngeal Carcinoma Treated by Intensity Modulated Radiation Therapy in Long-Term Survivors. International Journal of Clinical and Experimental Medicine, 8, 5658-5666.
|
[4]
|
Peng, G., Wang, T., Yang, K.-Y., Zhang, S., Zhang, T., Li, Q., et al. (2012) A Prospective, Randomized Study Comparing Outcomes and Toxicities of Intensity-Modulated Radiotherapy vs. Conventional Two-Dimensional Radiotherapy for the Treatment of Nasopharyngeal Carcinoma. Radiotherapy & Oncology, 104, 286-293.
https://doi.org/10.1016/j.radonc.2012.08.013
|
[5]
|
Trotti, A., Bellm, L.A., Epstein, J.B., Frame, D., Fuchs, H.J., Gwede, C.K., et al. (2003) Mucositis Incidence, Severity and Associated Outcomes in Patients with Head and Neck Cancer Receiving Radiotherapy with or without Chemotherapy: A Systematic Literature Review. Radiotherapy & On-cology, 66, 253-262.
https://doi.org/10.1016/S0167-8140(02)00404-8
|
[6]
|
原浩, 韦燕, 梁国栋. 鼻咽癌患者发生重度放射性口腔黏膜炎的危险因素分析[J]. 中国现代医药杂志, 2022, 24(7): 35-38.
|
[7]
|
刘建辉, 罗妍, 陈晓, 徐向升, 周平. 放疗前中性粒细胞/淋巴细胞血小板/淋巴细胞预后营养指数及CA19-9与胰腺腺癌放疗后预后关系的分析[J]. 中国肿瘤临床, 2017, 44(6): 289-293.
|
[8]
|
汪庚明, 周燕, 孙谦, 丁建明, 周士祥, 陈蔓, 等. 局部晚期下咽癌患者放疗前NLR与PLR对预后的意义[J]. 中华全科医学, 2021, 19(5): 763-766.
|
[9]
|
陈阳, 陈方, 施朕善, 王磊. 淋巴细胞与中性粒细胞比值对食管鳞癌患者同步放化疗疗效及预后判断的临床意义[J]. 分子诊断与治疗杂志, 2022, 14(7): 1121-1124.
|
[10]
|
颜玲玲, 吴坚芬, 顾彬彬, 叶丽萍. 血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值对早期胃癌诊断的预测价值[J]. 中华消化杂志, 2022, 42(3): 163-170.
|
[11]
|
健康时报网. 首部CSCO头颈部肿瘤诊疗指南发布[J]. 中国肿瘤临床与康复, 2019, 26(5): 628.
|
[12]
|
Peterson, D.E., Boers-Doets, C.B., Bensadoun, R.J. and Herrstedt, J. (2015) Management of Oral and Gastrointestinal Mucosal Injury: ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up. Annals of Oncology, 26, V139-V151. https://doi.org/10.1093/annonc/mdv202
|
[13]
|
Sonis, S.T., Eilers, J.P., Epstein, J.B., LeVeque, F.G., Liggett Jr., W.H., Mulagha, M.T., et al. (1999) Validation of a New Scoring System for the Assessment of Clinical Trial Research of Oral Mucositis Induced by Radiation or Chemotherapy. Cancer, 85, 2103-2113.
https://doi.org/10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0
|
[14]
|
Sonis, S.T. (2009) Mucositis: The Impact, Biology and Therapeutic Opportunities of Oral Mucositis. Oral Oncology, 45, 1015-1020. https://doi.org/10.1016/j.oraloncology.2009.08.006
|
[15]
|
Eilers, J. and Million, R. (2007) Prevention and Manage-ment of Oral Mucositis in Patients with Cancer. Seminars in Oncology Nursing, 23, 201-212. https://doi.org/10.1016/j.soncn.2007.05.005
|
[16]
|
Zenda, S., Matsuura, K., Tachibana, H., Homma, A., Kirita, T., Monden, N., et al. (2011) Multicenter Phase II Study of an Opioid-Based Pain Control Program for Head and Neck Cancer Patients Receiving Chemoradiotherapy. Radiotherapy & Oncology, 101, 410-414. https://doi.org/10.1016/j.radonc.2011.09.016
|
[17]
|
Lee, Y.H., Choi, H.-S., Jeong, H., Kang, K.M., Song, J.H., Lee, W.S., et al. (2018) Neutrophil-Lymphocyte Ratio and a Dosimetric Factor for Predicting Symptomatic Radiation Pneu-monitis in Non-Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy. The Clinical Respiratory Journal, 12, 1264-1273.
https://doi.org/10.1111/crj.12660
|
[18]
|
Sonis, S.T. (2013) Oral Mucositis in Head and Neck Cancer: Risk, Biology, and Management. American Society of Clinical Oncology Educational Book, 33, e236-e240. https://doi.org/10.14694/EdBook_AM.2013.33.e236
|
[19]
|
Kang, M., Jeong, C.W., Kwak, C., Kim, H.H. and Ku, J.H. (2016) The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy. Annals of Surgical Oncology, 23, 335-342. https://doi.org/10.1245/s10434-015-4708-8
|
[20]
|
Han, S., Liu, Y., Li, Q., Li, Z., Hou, H. and Wu, A. (2015) Pre-Treatment Neutrophil-to-Lymphocyte Ratio Is Associated with Neutrophil and T-Cell Infiltration and Predicts Clini-cal Outcome in Patients with Glioblastoma. BMC Cancer, 15, Article No. 617. https://doi.org/10.1186/s12885-015-1629-7
|
[21]
|
Tham, T., Bardash, Y., Herman, S.W. and Costantino, P.D. (2018) Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Head and Neck Cancer: A Systematic Review and Me-ta-Analysis. Head & Neck, 40, 2546-2557.
https://doi.org/10.1002/hed.25324
|
[22]
|
Motomura, T., Shirabe, K., Mano, Y., Muto, J., Toshima, T., Umemoto, Y., et al. (2013) Neutrophil-Lymphocyte Ratio Reflects Hepatocellular Carcinoma Recurrence after Liver Transplantation via Inflammatory Microenvironment. Journal of Hepatology, 58, 58-64. https://doi.org/10.1016/j.jhep.2012.08.017
|
[23]
|
Kantola, T., Klintrup, K., Väyrynen, J.P., Vornanen, J., Bloigu, R., Karhu, T., et al. (2012) Stage-Dependent Alterations of the Serum Cytokine Pattern in Colorectal Carcinoma. British Journal of Cancer, 107, 1729-1736.
https://doi.org/10.1038/bjc.2012.456
|